DIAGNOS-Announces-Closing-of-First-Tranche-of-Private-Placement
DIAGNOS-Announces-Closing-of-First-Tranche-of-Private-Placement
DIAGNOS-souhaite-la-bienvenue-a-Dr-Philippe-Couillard-au-sein-de-son-conseil-dadministration
DIAGNOS-souhaite-la-bienvenue-a-Dr-Philippe-Couillard-au-sein-de-son-conseil-dadministration
DIAGNOS-Inc.-to-Present-at-the-AI-Technology-Hybrid-Investor-Conference-April-11th
DIAGNOS-Inc.-to-Present-at-the-AI-Technology-Hybrid-Investor-Conference-April-11th
DIAGNOS-Announces-Grant-of-Stock-Options
DIAGNOS-Announces-Grant-of-Stock-Options
DIAGNOS-Welcomes-Dr.-Philippe-Couillard-to-its-Board-of-Directors
DIAGNOS-Welcomes-Dr.-Philippe-Couillard-to-its-Board-of-Directors
DIAGNOS-inc.-presentera-a-la-conference-des-investisseurs-hybrides-AI-Technologie-le-11-avril
DIAGNOS-inc.-presentera-a-la-conference-des-investisseurs-hybrides-AI-Technologie-le-11-avril
DIAGNOS-accelerera-la-demande-de-licence-dinstrument-medical-a-Sante-Canada-et-a-la-FDA-des-Etats-Unis-concernant-ses-4-nouveaux-modules-danalyse^J-et-prevoit-la-certification-ISO-27001
DIAGNOS-accelerera-la-demande-de-licence-dinstrument-medical-a-Sante-Canada-et-a-la-FDA-des-Etats-Unis-concernant-ses-4-nouveaux-modules-danalyse^J-et-prevoit-la-certification-ISO-27001
DIAGNOS-annonce-un-octroi-doptions-dachat-dactions
DIAGNOS-annonce-un-octroi-doptions-dachat-dactions
DIAGNOS-to-expedite-application-for-Medical-Device-License-to-Health-Canada-and-US-FDA-related-to-its-4-new-analysis-modules^J-and-is-planning-ISO-27001-certification
DIAGNOS-to-expedite-application-for-Medical-Device-License-to-Health-Canada-and-US-FDA-related-to-its-4-new-analysis-modules^J-and-is-planning-ISO-27001-certification
DIAGNOS-depose-une-pre-soumission-aupres-de-la-FDA-pour-son-systeme-CARA-Entree-strategique-sur-le-marche-americain-de-loptometrie-avec-le-soutien-dORA-LLC
DIAGNOS-depose-une-pre-soumission-aupres-de-la-FDA-pour-son-systeme-CARA-Entree-strategique-sur-le-marche-americain-de-loptometrie-avec-le-soutien-dORA-LLC
